A specific Hyderabad-based CDMO pharma company (currently ~INR 45,000-48,000 Cr market cap) is expected to continue performing well for the next 2-3 quarters (6-9 months).
"I still believe another two to three quarters definitely might might play out is our analysis might be wrong but we made enough that even if I'm wrong I will still make a good amount and walk out"
